P8A:SGX
Cordlife Group Ltd
SGD 0.12
0.00%
(0.00) 1D
Sep 29, 9:34:08 AM GMT+8 · SGD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for P8A...
Mkt. cap
32.37M
Avg. vol.
1.15K
Volume
0.00
52-wk high
SGD 0.26
52-wk low
SGD 0.10
EPS
-SGD 0.04
Shares outstanding
267.53M
No. of employees
111
Mkt. cap
32.37M
Avg. vol.
1.15K
Volume
0.00
52-wk high
SGD 0.26
52-wk low
SGD 0.10
EPS
-SGD 0.04
Shares outstanding
267.53M
No. of employees
111
News stories
From web sources and news partners
Reuters
·
15 minutes ago
Wall St Week Ahead Bank earnings, CPI headline busy markets week as S&P 500 hovers near records
Kiplinger
·
37 minutes ago
The S&P 500 Is More Concentrated Than You Think. These ETFs Spread Your Risk
The Mighty 790 KFGO
·
5 minutes ago
AI-centered US stock bull market nears four-year anniversary
AOL.com
·
37 minutes ago
History says midterms could hand the S&P 500 a year-end rally: Chart of the Day
Profile
Cordlife Group Limited, is a consumer health company incorporated in May 2001 and a provider of cord blood and cord lining banking services in Asia. Cordlife has been listed on the mainboard of SGX since March 2012.
Cordlife Group owns the largest network of cord blood banks in Asia with full stem cell processing and storage facilities in six markets including Singapore, Hong Kong, India, Indonesia, and the Philippines. Beyond cord blood and cord lining banking, Cordlife offers diagnostics services, particularly for the mother and child segment, including urine-based newborn metabolic screening, non-invasive prenatal testing, paediatric vision screening and family genetic screening services.
Cordlife's stem cell processing and storage facilities in Singapore, Hong Kong, India, Indonesia, the Philippines and Malaysia were accredited by AABB until 2024 when its accreditation was withdrawn.
In November 2023, the Ministry of Health of Singapore revealed that Cordlife Group had exposed cryopreserved cord blood units at suboptimal temperatures, damaging the cord blood units belonging to at least 2,150 clients and rendering them unsuitable for stem cell transplant purposes. Wikipedia
About Cordlife Group Ltd
CEOYiu Pang Fai
Employees111
FoundedMay 2, 2001
Headquarters-
SectorHealth care provider
Websitecordlife.com